Participants will:
- Understand that excess abdominal adiposity is the key underlying cause of pre-diabetes and type 2 diabetes
- Know the common ways to assess abdominal adiposity
- Understand the key physiological mechanisms that cause people with abdominal adiposity to develop pre-diabetes and type 2 diabetes
- Know how VLEDs assist with the reduction of excess adipose tissue
- Understand who is eligible to use VLEDs
- Know what the new regulatory requirements are for VLEDs in Australia and New Zealand
- Understand how the current Australian/NZ marketplace measures up to those requirements